<DOC>
	<DOC>NCT01843218</DOC>
	<brief_summary>Erectile dysfunction will be explored by recording R / P and self-administered questionnaire IIEF-5.</brief_summary>
	<brief_title>Erectile Rating During the Treatment of Rectal Cancers Localized</brief_title>
	<detailed_description>Erectile dysfunction will be explored by recording R / P and self-administered questionnaire IIEF-5. This dual evaluation will be made before the beginning of the therapeutic treatment and 3 months and 12 months after surgery. Assessed by IIEF-5 will be made only 6, 18 and 24 months after surgery. There will be no changes made to support oncology patients.</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>1. Male patient. 2. Age greater than 18 years. 3. Neoplastic rectal stage ≤ T3. 4. Patient sexually active before diagnosis. 5. Laparoscopic surgery. 6. Medicosurgical institute Bergonié. 7. Patient information and consent for participation in the study. 1. Patients already treated for erectile dysfunction. 2. Absence of sexual activity before diagnosis. 3. Presence of secondary lesions at diagnosis (M +). 4. Classified T4 tumor preoperatively. 5. Surgery by laparotomy. 6. History of pelvic cancer surgery prostate or bladder. 7. History of pelvic radiotherapy (outside of the current process). 8. History of prostate or bladder neoplasia known. 9. Other neoplastic known. 10. Patient for psychological, social, family or geographical could not be treated or monitored regularly according to the criteria of the study, patient deprived of liberty or under guardianship.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Localized rectal cancer in a male patient</keyword>
</DOC>